<SEC-DOCUMENT>0001493152-25-010981.txt : 20250320
<SEC-HEADER>0001493152-25-010981.hdr.sgml : 20250320
<ACCEPTANCE-DATETIME>20250320074535
ACCESSION NUMBER:		0001493152-25-010981
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20250320
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250320
DATE AS OF CHANGE:		20250320

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ABEONA THERAPEUTICS INC.
		CENTRAL INDEX KEY:			0000318306
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				830221517
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15771
		FILM NUMBER:		25754528

	BUSINESS ADDRESS:	
		STREET 1:		6555 CARNEGIE AVE, 4TH FLOOR
		CITY:			CLEVELAND
		STATE:			OH
		ZIP:			44103
		BUSINESS PHONE:		646-813-4701

	MAIL ADDRESS:	
		STREET 1:		6555 CARNEGIE AVE, 4TH FLOOR
		CITY:			CLEVELAND
		STATE:			OH
		ZIP:			44103

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PLASMATECH BIOPHARMACEUTICALS INC
		DATE OF NAME CHANGE:	20140922

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ACCESS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19960209

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHEMEX PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:ABEO="http://abeonatherapeutics.com/20250320">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_036_ABEO_abeonatherapeutics.com_20250320 -->
<!-- Field: Set; Name: xdx; ID: xdx_04F_20250320_20250320 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_054_edei%2D%2DEntityCentralIndexKey_0000318306 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-03-20" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-03-20" id="Fact000004" name="dei:EntityCentralIndexKey">0000318306</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="abeo-20250320.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-03-20">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000318306</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-03-20</xbrli:startDate>
        <xbrli:endDate>2025-03-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
DC 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_90A_edei--DocumentType_c20250320__20250320_zYI5WVTqInnk"><ix:nonNumeric contextRef="AsOf2025-03-20" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PURSUANT
TO SECTION 13 OR 15(d) OF THE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITIES
EXCHANGE ACT OF 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of report (Date of earliest event reported): <b><span id="xdx_90B_edei--DocumentPeriodEndDate_c20250320__20250320_z9Lh16R0YYgk"><ix:nonNumeric contextRef="AsOf2025-03-20" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">March 20, 2025</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span style="text-decoration: underline"><span id="xdx_904_edei--EntityRegistrantName_c20250320__20250320_zputvFzgMnO8"><ix:nonNumeric contextRef="AsOf2025-03-20" id="Fact000011" name="dei:EntityRegistrantName">ABEONA
THERAPEUTICS INC.</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_905_edei--EntityIncorporationStateCountryCode_c20250320__20250320_zUXUZguH5WI"><ix:nonNumeric contextRef="AsOf2025-03-20" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_edei--EntityFileNumber_c20250320__20250320_zuSnqljQZCq8"><ix:nonNumeric contextRef="AsOf2025-03-20" id="Fact000013" name="dei:EntityFileNumber">001-15771</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--EntityTaxIdentificationNumber_c20250320__20250320_zNFIwPzdiU8a"><ix:nonNumeric contextRef="AsOf2025-03-20" id="Fact000014" name="dei:EntityTaxIdentificationNumber">83-0221517</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
    incorporation)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
    Number)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    No.)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_905_edei--EntityAddressAddressLine1_c20250320__20250320_zI3YmmQvohV8"><ix:nonNumeric contextRef="AsOf2025-03-20" id="Fact000015" name="dei:EntityAddressAddressLine1">6555
Carnegie Ave</ix:nonNumeric></span>, <span id="xdx_901_edei--EntityAddressAddressLine2_c20250320__20250320_zu1DIBSquFQd"><ix:nonNumeric contextRef="AsOf2025-03-20" id="Fact000016" name="dei:EntityAddressAddressLine2">4th Floor</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--EntityAddressCityOrTown_c20250320__20250320_z44wx2GfIe4j"><ix:nonNumeric contextRef="AsOf2025-03-20" id="Fact000017" name="dei:EntityAddressCityOrTown">Cleveland</ix:nonNumeric></span>,
<span id="xdx_90F_edei--EntityAddressStateOrProvince_c20250320__20250320_zwJ3bxnMt7J9"><ix:nonNumeric contextRef="AsOf2025-03-20" id="Fact000018" name="dei:EntityAddressStateOrProvince">OH</ix:nonNumeric></span> <span id="xdx_90C_edei--EntityAddressPostalZipCode_c20250320__20250320_zZvefcf5fYyf"><ix:nonNumeric contextRef="AsOf2025-03-20" id="Fact000019" name="dei:EntityAddressPostalZipCode">44103</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>(Address
of principal executive offices) (Zip Code)</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_904_edei--CityAreaCode_c20250320__20250320_zsHk2Z64DaYj"><ix:nonNumeric contextRef="AsOf2025-03-20" id="Fact000020" name="dei:CityAreaCode">(646)</ix:nonNumeric></span>
<span id="xdx_905_edei--LocalPhoneNumber_c20250320__20250320_zCeOjrB4Q9d7"><ix:nonNumeric contextRef="AsOf2025-03-20" id="Fact000021" name="dei:LocalPhoneNumber">813-4701</ix:nonNumeric></span><br/>
</span></b>(Registrant&#8217;s telephone number, including area code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">N/A</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
name or former address, if changed since last report)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--WrittenCommunications_c20250320__20250320_zcNUnCYvjnt2"><ix:nonNumeric contextRef="AsOf2025-03-20" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--SolicitingMaterial_c20250320__20250320_zuEDDpQM3Ny9"><ix:nonNumeric contextRef="AsOf2025-03-20" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--PreCommencementTenderOffer_c20250320__20250320_zsoyXSlYSLTa"><ix:nonNumeric contextRef="AsOf2025-03-20" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--PreCommencementIssuerTenderOffer_c20250320__20250320_zn33bNq3Nkwk"><ix:nonNumeric contextRef="AsOf2025-03-20" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of Each Class</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    Symbol</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of each exchange on which registered</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_edei--Security12bTitle_c20250320__20250320_z88MJekN6Rqb"><ix:nonNumeric contextRef="AsOf2025-03-20" id="Fact000026" name="dei:Security12bTitle">Common
    Stock, $0.01 par value</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_905_edei--TradingSymbol_c20250320__20250320_zzQnXmIHG6Va"><ix:nonNumeric contextRef="AsOf2025-03-20" id="Fact000027" name="dei:TradingSymbol">ABEO</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span><span id="xdx_908_edei--SecurityExchangeName_c20250320__20250320_zEPLvzRDYnPg"><ix:nonNumeric contextRef="AsOf2025-03-20" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span>
    Capital Markets</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_906_edei--EntityEmergingGrowthCompany_c20250320__20250320_z2mC73BQ5Dxj"><ix:nonNumeric contextRef="AsOf2025-03-20" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
2.02. Results of Operations and Financial Condition.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 20, 2025, Abeona Therapeutics Inc. issued a press release regarding its financial results for the year ended December 31, 2024.
The full text of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information in Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed &#8220;filed&#8221;
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject
to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933,
as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01 Financial Statements and Exhibits.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Exhibits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    No.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-1.htm">Press release dated March 20, 2025</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abeona
    Therapeutics Inc.</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant)</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 50%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Joseph Vazzano</i></span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&#160;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joseph
    Vazzano</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</span></td>
    </tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
March 20, 2025</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjV0KwkAMhE/QO4R9FvsjBe2blipiFSkivq42lcV2U7Lr35G8pdsWMQRCmPlmhBiJFS1VjQynRZHDAZu2lhahwAoZ9QWdI11vEnC3wKsylqW2/fsDU3IMOiYeR/HZCb31oQyWCQQTP5z6UQxhkMQzmG+F1+kp6UqVqK2SNUhdwp6pZYVW8ntIOMgXaWrefdUR2SjSCYTjYJA/EAVhBDt6yCfxzUCep8Ib9eOJFdO9da7sZVF3JGQ1Nq7ODPR/vS8FIEqJ -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex99-1_001.jpg" ALT="" STYLE="height: 122px; width: 350px">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Abeona
Therapeutics<SUP>&reg;</SUP> Reports Full Year 2024 Financial Results, Provides Pz-cel Regulatory Update and Commercial Launch Plans</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>FDA
priority review of pz-cel Biologics License Application (BLA) progressing with Prescription Drug User Fee Act (PDUFA) target action date
of&nbsp;April&nbsp;29, 2025</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Launch
preparations on track toward goal to treat first patient in 3Q 2025</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CLEVELAND,
March 20, 2025 &ndash; Abeona Therapeutics Inc. (Nasdaq: ABEO) today reported financial results for the full year of 2024, and announced
progress in the ongoing review with the U.S. Food and Drug Administration (FDA) regarding prademagene zamikeracel (pz-cel) and plans
for the U.S. commercial launch of pz-cel for recessive dystrophic epidermolysis bullosa (RDEB), if approved. The Company will host a
conference call and webcast today at 8:30 a.m. ET.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;The
RDEB community continues to highlight the unmet medical need for new therapies that could provide long-lasting healing and pain reduction,
even in tough large, chronic RDEB wounds,&rdquo; said Vish Seshadri, Chief Executive Officer of Abeona. &ldquo;With a PDUFA date of April
29, 2025, the BLA review by the FDA is on track as discussions are underway regarding post-marketing requirements and commitments as
well as the draft label.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fourth
Quarter and Recent Progress</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Pz-cel
for RDEB</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; padding-top: 1pt; padding-right: 6pt; padding-bottom: 1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 1pt; padding-right: 6pt; padding-bottom: 1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abeona
    continues to work with the <FONT STYLE="font-weight: normal">FDA </FONT>to finalize the review of its <FONT STYLE="font-weight: normal">Biologics
    License Application (BLA) for pz-cel as a potential new treatment for patients with </FONT>RDEB<FONT STYLE="font-weight: normal">.
    </FONT>In November 2024, the FDA accepted the BLA resubmission for review and set a PDUFA target action date of April 29, 2025. On
    March 14, 2025, Abeona received draft United States Prescribing Information (USPI) from the FDA to initiate discussion on the label
    for pz-cel. Discussions are also ongoing with the FDA on post-approval marketing requirements and commitments for pz-cel. If approved,
    the Company anticipates the first patient treatment with pz-cel in the third quarter of 2025. Abeona may be eligible for a Priority
    Review Voucher (PRV) should pz-cel be approved.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 1pt; padding-right: 6pt; padding-bottom: 1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 1pt; padding-right: 6pt; padding-bottom: 1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    anticipation of potential FDA approval of <FONT STYLE="font-weight: normal">pz-cel, </FONT>Abeona continues its commercialization
    efforts, including progress toward onboarding five geographically dispersed, well-recognized epidermolysis bullosa treatment centers
    in the U.S. as pz-cel qualified treatment centers (QTCs), engaging payers to ensure patient access, and educating key stakeholders.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 1pt; padding-right: 6pt; padding-bottom: 1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 1pt; padding-right: 6pt; padding-bottom: 1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    preparation for potential pz-cel launch, Abeona has hired and trained personnel to support commercialization, manufacturing, supply
    chain and quality.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 1pt; padding-right: 6pt; padding-bottom: 1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 1pt; padding-right: 6pt; padding-bottom: 1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abeona
    entered into a lease agreement for additional facility space in Cleveland, Ohio to enable expansion of manufacturing capacity for
    pz-cel beyond the current planned manufacturing footprint.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 1pt; padding-right: 6pt; padding-bottom: 1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 1pt; padding-right: 6pt; padding-bottom: 1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obtained
    two additional patents from the United States Patent and Trademark Office for <FONT STYLE="font-weight: normal">pz-cel</FONT>, extending
    patent protection on the use of pz-cel for the treatment of RDEB to June 2037 and patent protection on the packaging and transport
    system for pz-cel to July 2040.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Pipeline
and partnered programs</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; padding-top: 1pt; padding-right: 6pt; padding-bottom: 1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 1pt; padding-right: 6pt; padding-bottom: 1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">In
    December 2024, Ultragenyx submitted a BLA to the FDA seeking accelerated approval for UX111 (formerly ABO-102) AAV gene therapy as
    a treatment for patients with Sanfilippo syndrome type A (MPS IIIA). In February 2025, Ultragenyx announced FDA acceptance and Priority
    Review of the UX111 BLA with a PDUFA date of August 18, 2025.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Full
Year 2024 Financial Results and Cash Runway Guidance</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash,
cash equivalents, short-term investments and restricted cash totaled $98.1 million as of December 31, 2024, compared to $52.6 million
as of December 31, 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abeona
estimates that its current cash and cash equivalents, short-term investments and restricted cash, as well as its credit facility, are
sufficient resources to fund operations into 2026, before accounting for any potential revenue from commercial sales of pz-cel, if approved,
or proceeds from the sale of a PRV, if awarded by the FDA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development expenses for the full year ended December 31, 2024 were $34.4 million, compared to $31.1 million for the full year ended
December 31, 2023, primarily a result of increased headcount related to manufacturing capacity expansion in preparation for the potential
launch of pz-cel, partially offset by reduced spending on clinical and development work. General and administrative (G&amp;A) expenses
were $29.9 million for the full year ended December 31, 2024, compared to $19.0 million for the year ended December 31, 2023. The increase
in G&amp;A expenses is primarily due to commercial launch preparation costs. Net loss for the full year ended December 31, 2024 was $63.7
million, or $1.55 loss per common share as compared to $54.2 million, or $2.53 loss per common share, for the full year of 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Conference
Call Details</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will host a conference call and webcast on Thursday, March 20, 2025, at 8:30 a.m. ET, to discuss the financial results and company
updates. To access the call, dial 877-545-0523 (U.S. toll-free) or 973-528-0016 (international) and Entry Code: 712069 five minutes prior
to the start of the call. A live, listen-only webcast and archived replay of the call can be accessed on the Investors &amp; Media section
of Abeona&rsquo;s website at <U>https://investors.abeonatherapeutics.com/events</U>. The archived webcast replay will be available for
30 days following the call.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Abeona Therapeutics </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abeona
Therapeutics Inc. is a clinical-stage biopharmaceutical company developing cell and gene therapies for serious diseases. Prademagene
zamikeracel (pz-cel) is Abeona&rsquo;s investigational autologous, COL7A1 gene-corrected epidermal sheets currently in development for
recessive dystrophic epidermolysis bullosa. The Company&rsquo;s fully integrated cell and gene therapy cGMP manufacturing facility served
as the manufacturing site for pz-cel used in its Phase 3 VIITAL&trade; trial, and is capable of supporting commercial production of pz-cel
upon FDA approval. The Company&rsquo;s development portfolio also features AAV-based gene therapies for ophthalmic diseases with high
unmet medical need. Abeona&rsquo;s novel, next-generation AAV capsids are being evaluated to improve tropism profiles for a variety of
devastating diseases. For more information, visit <U>www.abeonatherapeutics.com.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward-Looking
Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><I>This
press release contains certain statements that are forward-looking within the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and that involve risks and uncertainties. We have attempted
to identify forward-looking statements by such terminology as &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;believe,&rdquo; &ldquo;anticipate,&rdquo;
&ldquo;expect,&rdquo; &ldquo;intend,&rdquo; &ldquo;potential,&rdquo; and similar words and expressions (as well as other words or expressions
referencing future events, conditions or circumstances), which constitute and are intended to identify forward-looking statements. Actual
results may differ materially from those indicated by such forward-looking statements as a result of various important factors, numerous
risks and uncertainties, including but not limited to, the timing and outcome of the FDA&rsquo;s review of our BLA resubmission for pz-cel;
</I></FONT><I><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our plans to continue development of AAV-based
gene therapies designed to treat ophthalmic diseases; <FONT STYLE="font-weight: normal">the FDA&rsquo;s grant of a Priority Review Voucher
(&ldquo;PRV&rdquo;) </FONT>in connection with the pz-cel BLA; the achievement of or expected timing, progress and results of clinical
development, clinical trials and potential regulatory approvals; our pipeline of product candidates; our belief that pz-cel could potentially
benefit patients with RDEB; our belief in the adequacy of the clinical trial data from our VIITAL&trade; clinical trial, together with
the data generated in the pz-cel program to date, to support pz-cel&rsquo;s regulatory approval; our dependence upon our third-party
customers and vendors and their compliance with regulatory bodies; our estimates regarding expenses, future revenues, capital requirements,
and needs for additional financing; our intellectual property position and our ability to obtain, maintain and enforce intellectual property
protection and exclusivity for our proprietary assets; our estimates regarding the size of the potential markets for our product candidates,
the strength of our commercialization strategies and our ability to serve and supply those markets; and future economic conditions or
performance; <FONT STYLE="font-weight: normal">risks associated with data analysis and reporting; and other risks disclosed in the Company&rsquo;s
most recent Annual Report on Form 10-K and subsequent periodic reports filed with the Securities and Exchange Commission. The Company
undertakes no obligation to revise the forward-looking statements or to update them to reflect events or circumstances occurring after
the date of this press release, whether as a result of new information, future developments or otherwise, except as required by the federal
securities laws.</FONT></FONT></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investor
and Media Contact:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Greg
Gin<BR>
VP, Investor Relations and Corporate Communications<BR>
Abeona Therapeutics</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>ir@abeonatherapeutics.com
</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ABEONA
THERAPEUTICS INC. AND SUBSIDIARIES<BR>
</B>Condensed Consolidated Statements of Operations and Comprehensive Loss</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
in thousands, except share and per share amounts)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">For the years ended December 31,</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2024</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2023</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Revenues:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; width: 60%; text-align: left">License and other revenues</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">3,500</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Expenses:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt">Royalties</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,605</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Research and development</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,360</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">31,091</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">General and administrative</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">29,851</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,004</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Gain on operating lease right-of-use assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(1,065</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Total expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">64,211</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">50,635</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Loss from operations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(64,211</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(47,135</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Interest income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,246</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,117</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Interest expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,208</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(418</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Change in fair value of warrant and derivative liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(755</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(11,695</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Other income</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,194</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,943</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Net loss</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(63,734</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(54,188</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Basic and diluted loss per common share</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(1.55</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(2.53</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Weighted average number of common shares outstanding - basic and diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">41,048,206</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">21,380,476</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Other comprehensive income (loss):</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Change in unrealized gains related to available-for-sale debt securities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">74</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Foreign currency translation adjustments</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">29</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Comprehensive loss</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(63,660</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(54,125</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ABEONA
THERAPEUTICS INC. AND SUBSIDIARIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Condensed
Consolidated Balance Sheets</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
in thousands, except share and per share amounts)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">December 31, 2024</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">December 31, 2023</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: center">ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Current assets:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left; padding-left: 10pt">Cash and cash equivalents</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">23,357</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">14,473</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Short-term investments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">74,363</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">37,753</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Restricted cash</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">338</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">338</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Other receivables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,652</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,444</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Prepaid expenses and other current assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,143</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">729</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">Total current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100,853</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">55,737</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Property and equipment, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,430</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,533</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Operating lease right-of-use assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,552</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,455</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Other assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">96</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">277</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">Total assets</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">108,931</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">64,002</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: center">LIABILITIES AND STOCKHOLDERS&rsquo; EQUITY</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Current liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3,441</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,858</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Accrued expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,333</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,985</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Current portion of long-term debt</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,926</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Current portion of operating lease liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">823</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">998</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Current portion payable to licensor</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,580</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Other current liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">64</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 20pt">Total current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,587</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,422</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Long-term operating lease liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,262</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,402</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Long-term debt</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,037</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Warrant liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">32,014</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">31,352</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 20pt">Total liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">64,900</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">49,176</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Commitments and contingencies</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Stockholders&rsquo; equity:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Preferred stock - $0.01 par value; authorized 2,000,000 shares; No shares issued and outstanding as of December 31, 2024 and 2023, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Common stock - $0.01 par value; authorized 200,000,000 shares; 45,644,091 and 26,523,878 shares issued and outstanding as of December 31, 2024 and 2023, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">457</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">265</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Additional paid-in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">856,824</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">764,151</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Accumulated deficit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(813,258</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(749,524</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Accumulated other comprehensive loss</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">8</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(66</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total stockholders&rsquo; equity</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">44,031</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">14,826</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">Total liabilities and stockholders&rsquo; equity</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">108,931</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">64,002</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_001.jpg
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 9 !D  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #1 E@# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "D)P,_3J<=P#V/0<].>GO2TC<@@9YXXQQ[\\<4?
MUIO\KZ!_73]=/O(_,;T /. <]O4C@'M]:!(2,X'XD@>Y(QD >_)/05YC\7=?
M^(?A3P!XC\0?"SP)!\3?'>F6<$FA>![GQ':^%8=;E:\MX[Q3K-[!<6T,UKI\
MEW>P6[Q9OIK5+)9K=[B.9?([3]H+Q#X!_9WO/CA^TI\.K[X3ZEH4!N_$O@OP
MQJ$GQ+U"RM;G5K;1]&ECDT.QB EU&6]@ENXI6-MH4+27&JZE#;PSR0>=B<TP
MN$JUJ6)=:DJ&!JYE7Q-3"8F&74<+1:]M[3,I0>#C5HPO5G0=55I4TYQBXIV\
MS$YM@\)B*U'%2KX>.'R^KFE?%U,'B8991PM!I5U6S24'A(U:2:J2H.:JN%YI
M<J;7U:C;U#>N?7L2._/:G5\__ K]HGX;_'WX:Q?%/P5=:U8>%$U#5--NY/%^
ME7'AR[L;O2%M9M1^T?;6^RRVEM'>P-)J%G<W6G#$]N;@7-I<I%ZUX?\ &?A'
MQ9;2WOA7Q/X?\3V<$I@GO/#FL:=KEI#./^6$USI=S=PQ3XR1%(ZR%5=@NU'(
MVPV/P.+I86MA<;A<13QM%8C!SIUJ2>*H-.2K8>E*I"M4IVC)N4*,E%1ES22B
MV;X;,,#C*.%KX3&8;$T<;0CB<'5I58..+P\N:U?#Q<U.K2]V5YTX5(PY6IRA
M:[Z:BH5GC8@ G)&<%2" 1D9!'&??GIGJ,N,J+U)SQP%8DY[@ $D#N0..]=2E
M&2O%J2UUBU):.SUCS+1Z/5M/=([.C?1;O5VMOLGW7<DHI,C]">AZ#_/'KS2@
M@\BGW\MQ76GFKKT[A1110,**** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHI&. ?PZ\]Z3=DW9OR6[\EM^:$]$]OGM\[#716R26'RX.T
MXR.<CUP<],X.!QUSE7AM193O<1&>W6WE,T7EO=O)#'$6=$MHHYI+AY$5D$$2
M223D^6B2,VTY'C+QOX/^'OA[4O%WCSQ3X=\%>%M(BCFU7Q-XJUG3O#^@Z9'/
M,D$+7NJZI<6MG;&:>6.&$RRKYDLD<2%I75*_/+XDZ_\ MD_''XK_  >^(?["
M7[2O[*NI_LJV4ME8?%:&]M(/'^J:IJMCJLTWB2#^V?#PUA;Y9?#\^G6NC:1H
M_B+P%JVAZT);O6[O4K*XMXK?U\IR6KF]1^UQ>"RK TZ6*G4S3-HX^AE,L3AJ
M$JT,NCF&&RC-*<<?C.5X;"4*E.,*U>I&-2<(KF?@YSGM#*J<80PN*S3'U9X>
M%/*<K_L[%9K&CBJCH/,9Y;B\TR^<\OPJDZV,J)U.3#0J-4Y-MPW_ (8_%W]G
M7_@IY\!OBYX+\*:9\6_#7@'3/%9^'?B1=?\ "NJ_##Q!#JNC2Z;XBL;K05O5
MN;2>P\U+::YTB]A:\L\/8^)M!L'O8(I?/=$_8TU7]A_X1_&#QC^R-'XF^)OQ
MQ\0:-INFZ;9^-=0TR73DTRVU:TGOIM+\*V,6B:/JFN6%JEQ?6*:G<RW-PT:6
MEJS6YGTS4?U7BB5%!1%0%W<@ <EW+.S;<AY')+.Y8EWP[EVYJQ7R_$60<-YU
MF]?-\ORJKD^)CA*V"R?&3QU3,,XR;#5\.Z<_89A*E@:%3$0KU*^(HUGE=)T_
M:JBH\L%,\^7".%QD,+C<VGAL3Q3A<OQ.!H\49=@IY3B<(Z\,72IXG+L'3S'%
M87"U,/2Q,8T54^N6E3G4C.+K6H?A#^QU\;O^"G'BOXW>'M%^*_@CQ+J/PTN;
MB1/&][\0OAM8_#RR\-Z6T;A]4T/6(-'\/RSZQ!*(A!I$(U.&]CDDA>QB\P:A
M;?I#KG[='[(WACQ)<>#]<^/WP_M=?MKP6%Y;17M[J%A9WN5#6]SK>FV5YH4#
M1.?+F:;442"5)8IF22*1(_JC6[&WU72K[2KP2M9:I:SZ;>I!,]O,]I?PR6MR
ML5Q&\4T$AAE<1SP2)-$^V2)A(JU_/9\7/^"0'@GX::?XN^(E]^T==>&?A%X5
MT_4_$>KMK'P^EUWQ5I.C68\YK6&72=;LK7Q!?L,VUD8-/L)[F:2VBBLBP"5^
M=8_#\:\%93AZ.03K<:IXK$8K,<RXHS2G1JY;A[TY.G"7M<-R89TH5J]7&2QE
M>&&FI*IA5"I"+^/QV&XZX#R7#T>')UN.5]:Q6,S7,^*\TAAZN5X5.C-QI)5J
M*6&=*.+Q%?%/'UH8:=*3J86,:T8+^A#2-8TW7-/L-6T;4+/5=+U.TAOM/U+3
MKJWOK"_L[J,26MY:7=K)-!<VT\3"6&>*1XID.Z-B,XUP1@<@_I^E?SY?!G_@
MJE^SS\ ? _@[X->!OA)\8=<\ >![6?2K'Q5KNN>%$\2:G'=ZE=ZI?:O/HBRK
M9K]IO;VZNH;$ZI;M8V\D%F(85@58_P!L_@K\8?!'QZ^&WAOXI?#R_N-0\+>)
MH+IK)[RT?3]0M;FSN[G3M1T[4+*1W:VO=/U"UN;6X1)9H7,0FMYY[>6*5_K.
M'.,,CXDC&A@<QP>)S2CA*5?'X3"SQ$XT*DX0]JJ-6O@\(L5AZ=:7LEBJ*<)O
ME?)%R45]APQQMP_Q0EA\NS7 XO-*&$HXC,<'A)XFI'#U9P@JJHUL1@L&L3AJ
M=:7L8XFC%PF^5N$7)(];HIJ# QZ8'Y*/UQU]Z=7U?^2_%)_J?7_Y+\4G^H44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO 7P]^+FH7*075Q<RZAJ8M?!SF0M+-<Z;)-+-N_KB\"2^#YO!OA"?X?/H?\
MP@$_A?P_)X&;PO%;1>&SX0FTJTD\+GP]'9*MDNB'1&LCI2VBQVRV/D+"FQ5"
M_O'BG1J<)<(</<(Y5D7BAP?E^82EF.?Y7Q=CLOKY!FV9T,-AZGM<!#!QK1EC
ML-C/]KJPABL%AX4IX9SRSZQ05<_GSPIK1XOXRXDXPS7//#'B[,,N@LNR+->$
M<)CJ&>99EE6O7I^RQ\L9*A-8/$82/U6G.MA,9BJM6%>,<R6'JND^TCQL& 0.
M>",'J>W:GTQ 54 D'&>@P.I(QGV[]^O>GU_/ZV6B6FT6VEY)M)M+HVDWO97/
MZ*C\*O=NRU:2>W5)M)^2;2T2;L(RJPPP!&0>?4<@^Q%8?B+PSH'BS0]9\->)
M=(L==\/^(=,OM&UO1M4A6[TW5=+U&VDM+ZPOK67=%/:W-M*\4L;J058D88 C
M=I&Y5AG'!Y]..M*<(5(2A4A&I"<)PG"<8SA.$XN%2$H34HRC.#<9QE%QG%N,
MDTR:D(5(2A4A"I"<)PG"I&,X2A4A*%2$H34HRA.$YPG&47&<92C)-2:/YYOV
MT?V=O^"?/[(VI>%]6U[X=?%7Q/XC\;'5[WPW\,/#7C^32_";:?H;V<>HW>J:
M[J5A>ZQI%@EWJUC:VUK8:E?WK23;[>UBM[:2>/U_]D7_ (*>_!'4?$'@']G[
M3O@7J'P3\.ZA?Z=X0\!'0-:MO%'AZTU35KQH=/LM<B.FZ7JUM+J>IW")/JZ+
MJ]Q-J%S-=ZL\:M)=/]+?\%(/&_[.7P_^$&A7W[0?PDG^, U77[K2/ VCV,LF
MC:C8:U+ITD^HW4?C.&Y@O?#-H+"$&X-F]U+J+16T*:;=M"6@_,G]AW]H7]BZ
MP^/7@?0M-_9.U+P3XU\4^(;70?!7CFX\=ZE\3Y/#_B#5Y39Z:/[,\00V!TKS
MI;F"WGUK2(KV\L)IEF:-;1)]03^?,RJ1X4\0L-@LBS?@WAO!X^K@%B<NIY!4
MAC?9XJ<'+#8NO#!5W4JYG.T<#2H9I@Z5*;A..&3AS+^<,UK1X/\ $G#Y=P_G
MO O"^"S#$93&OED.':D<>Z6*J057"8S$4\OQ'-5S2HTL!2I9K@:%*3A46'BX
M<Q_2G;R-('+<$,!C(.#C.<@D,",$':N1C (P:L55ML#S5W;B&!)R6/*\'.YN
M"!D#)..3R:M5_0J_K?3R]Z4FFMFG)M-6OH?TE=.]FGJUI>R:=FM92:L]&G)V
M::Z!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 '^?\_K
M7S]^TQ^S7\+/VL?@_P"*/@E\9='OM8\$^*&LKJ3^R-4N]&UK2=8TJY2\T37M
M&U*T;=;:GI-[&EQ MQ%>:==CS+/5-/O]-N+FUF^@::^=IQUXQCKU'3Z5T83%
MXO+\5A\?@,36P>-P=:EB<)BL/.5.OAL30J1JT:]&I#WX5:52*E"<7=-;-7C+
MEQN"PF8X/%8#'8:CC,'C</6PN*PF(@JE#$X?$4Y4JU"K"349TZM.4H3C)I-.
MS:T<?X[?VI/^":'_  2X_P""?6O^%]:_:2^/G[1?CBV\2R7FK^$?@3X.L?!L
MWCGQ+HNE74,<]SK>L6=GH_V+P\MQ,NGW&KW-[X/FU.Y:ZAT:]^U65ZEO^P7[
M$'_!7']AG]H7Q!X'_9T^%MGX\^#NN0:)9^%?A?X!^)'AS2-*T_4M,\+:-';:
M5X6\,ZSX:\4>+](6^L="TCR].TK5=2L[^^CLQ#:M>WTT4,OO/[=?_!-#]GG]
MOBW\,:C\4CXK\*^//!6G7FD^&/B'X$U"ULM<@T74+I;^YT#6-/U.VU#1M>T8
M:BBZA90WEC]MTNZEOFTK4;%-2U&.[_-2;_@E7\*_^"9GPX\:_MC_  =\)?%'
M]L']HWX-V4&N?"KP;XG:*VT#2=6U34K;PYJGC,>#? >G1:OXEF\&>']:U;Q1
M=V;ZAJ$DEII$T^F0:5J=O;ZUIG]&RXGX(\2.$,LR_C;BSC[-_$M2Q&!R/!8B
MK@\+PYAL[S"HL%E]6FX83 Y%3RZM066TLSS#-)+,J=)5I)P5.A3J?S*N%>./
M#3C#,<?P3PIP)E'AG&GA\?G>+H4,9BN(<5DN74OKV9TIPCBL=GU;,Z$HYC/+
M,#EL'ELZ\Z3J*M*=2K3_ */$GCVCYL]>0,C +8 (RO8@#=NXQC-/,R#'WN0I
M&01PPR/O8_$=1Z5_$]\'?^"Z_P#P4EU_XLZ%HL'PT\'?&J35]>6S'P8\+?"_
M5=+U[45GO%$NEZ)?Z!<7?B'3-4AB=HH-2U>'6;.VDVW.JV,T22J?Z OVQ?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %,*$@#<<CG(]?QST[$@XZXI]& >HS2:O:
MS:LTTU:]UZZ":]'HU9[6>_\ 7Y;F+#HNF6EU->VFGZ?;7MP?](O(;*VANI@<
M B6X2,3/E<@L7X!R,')KC_&7PL^&?Q'ET]OB#\./ /CR322[:9)XR\&>'?%#
M::682.=/DUW3+]K0R2+O<VPCRXW%BPW-Z3@ 'L._)_S^ ZUYG\6OB=X1^#/@
M+Q%\3/'-WJ-EX3\*6<=]K-QI6DZCK=\D<UU;V4 @TW3(;B[N"]S=PHVR/RX5
M+SW$D,$<DJ3+&5LO4\=''3P+PU.=6IC8U\30JT*%.G)U)QKT:\)T8TZ*G\"Y
M/9J4''D?(^+%T\!#!XAXZCA'E]*E4Q&)AB:.&G@XPI)UZM:O2JX+$TZBCR2K
M3E5I57>+F[U+3.7^-'@'PSXI^&6MV>J_!3P-\;W\+Z5>ZUX*^%OC#1_"MSX?
MU7Q'H^EW$>A:=9OXGTG5-%\/37!;^S(=4%@QL+6>6-8I8Y'BE^)/A3X>\7?M
MF:#J?@C]LW]C#1OAQX/\!36T_P .KG^UM:\/217H7^S9=#T33+.?3-<TZTM]
M+BMV;4-,OU\/7D-M#9MILKP6DH;>?"'X??\ !0'4/"?[2'PT_:*_:(\#Z#I<
MP\/2>&M"O];\'6-KJ/AR5OMLVD:?=M!'HVJW/VJ);[6=,;6+#4@-L<Y=9(HO
MT_@@5(8%D$DC11+&99GWROL4*)97&!)+(<L[E069BP5<[1\HOKO%52%3%8C$
MOA2C[1X'+XYAEV;\/<48;,81J2S"MEM;"5:^!J0J0A4BH2P]6<Z<*E:4Y-I?
M'4< N*,PGF<Z-&EPXZ%"CAHT)<.YOE'&V758>UP>)Q\)Y(LWHT<%62>$PU;&
M35!TZ56G3I2IN$_,OAM\%?AA\'_!B?#OX:>#=)\+^#4EOKB;18/M-_'?7.IH
ML.I3ZM<ZM/?7^L7%[ $@N)]4N[N66UBBM=X@18UYCX,_LK_L[_LZ7?BK4?@;
M\&OA]\*[SQO<6\_BJZ\':!:Z3=:V+.6ZGL[:ZN(PTD>G6=Q?7DMGI=L8=/M&
MN)3;VT9?GWW*$C#8. V.021P,\9)&#^9_%BR+DKD#G[I;!7GJ58AA[DJ..?0
MU]=AJU? 8&KEF!K5L#EF(A0IULNPE>K@\!5IX5J>&HUL)AJ^%PLXX:JZE3#P
MG0G[-SG./++?ZZ.4Y3">!G'+<OA/*85:&5U?J.7QJY93KQ:K4<OJ/#1E@Z4X
MWA*GAN2,H-J47>[^'O#W_!-7]ASPE\:5_:$\/_LY^"=.^+$7B6Z\8VOB".X\
M13:98>++ZZFOI?$FE>#+K6IO!.EZTE]++J%I>Z=X>MY=/U*3^T-/:WO8TN*[
MWXQ_L3_LG_'[Q=I_C_XT_L__  T^(_C/3+6#3[?Q'XF\.V]UJ<UA:F9[73=5
MGA\A]>TVUDFF%M8:RM[:P"9UAA2/"+]5QLLF_G=M(!^N,@@]^#U'N.H(&=KF
MI:?H>D:AK>JW*66E:+9W>KZE=RR;(K33].MIKN\N9&8A1'#;Q22/D@87DU[%
M3B?B5XBCF-7B7/5B\%@_J6'QTLZS3ZQA,NA3Y9X2CBGCXU*."C1C.+P\)QH<
MBYW%U*=*I#SGPMPO2P>)P:X=X?IY?B<6\RQF%>398L)6QL9.H\=B,//+W2GB
M5).J\54INI!J7*U2E4IS_-7]H_2/^";7Q\LOB7X)_:0\-?#O7=,_9"\/6VJ^
M,KK5-+\2^%U^%/AFXM;4M9>'_%?@]=%U-=+MXX+"VU#PUX;OY[070T^Q.G2W
M!A4>J?LS?L]_L02_LUSZ'^S9\,OAM>?LX_'?0)[_ %>'3+'4]5LOB5HNJVTN
MD3?\)3J/BA[KQ;K$\$,=YI(@\07@O_#]Q#-!##97-LRK_/[I'B"Y^+G[+O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M.-#B\,_#SP;X2\">&H)Y[FWT#P9X=T?PMH<=Q<X,]U%I&A6ECIZ7%QM4S3B
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M?UKO^GY+T1ZZV7IWO^*T?JM]^H4444 %%%% !1110 4444 1, Q/7(P6!'!
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M?VU/V%/A_P#M7^&Y]3Q9>%/C!H]D\'A3Q['$PCNXHUE>W\/>+X(58ZGH,TS
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MG;_LB?\ !2;PH_Q%^'4&E6?A?0_BC?>'Y?&L=YX>L'7^RM-^*6A0O)K5Q?\
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M<'@Y4JC^1?V._P!A?]GK]B'P2_A+X+^$S#K>JVME%XS^)7B!H=3^(7CJZLU
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M_P#-_2K_ ,'%7[;X96/[/OP,9002I\(?%89P0< KX^R,C*GD'!R"#S7J</\
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M_JM*3NU0HT*;;]DC\)_^#A[_ ),"L/\ LX#X:_\ IF\<5^!__!,;]CSX@?\
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MA3E6K4K]O_P;N^#;W7OV_M1\2);.VG^ /V?OB'J=U.JD);7FN:[X#\-:?"Y
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M"VJP^$O$NN:$FH2Q)\L,UVM@MQ)"A*QM)Y? B05^PWQD_P"#C.X\964_@?\
M9(_9H\8ZA\2O%9A\/>"-=\>ZCI^HW-OKNJE[+3Y=&^&GA*T\07/B[7OMUQ:#
M2=%?Q#;6]S<,C7<%W"@L;W\:/V%=!\<^%/\ @JW\"/#7Q2DN)/B;HO[4!T[X
MAS7E_%J5W-XXM-7U6+Q2;R^@>2WO+X:S]K%U<6DCV[W F*,P"L?Z6\*.$?$'
M@_@[Q/PO&>(K9?@L?P9G&)RKAK'YI1Q^84ZM'*<]IXO-X8"&8XYX'"S=6CE\
MZT)Q5?%N'MJ494:=2I_-'BSQAX?<8<:^%N+X*I4,?BL%QMDM'->(\!E%7 8&
MK2K9ED<L+E%3&SP. ^OXN/LJV/A%TJKP^%4W"JH5ITX_Z&R=OQ_]&FIJKJ2"
M 2IR1CZ%MW3)[=/<$8.#5BOX9CU];?<Y*_HVG9]4KH_NY;+?X8K7H_>NGYJZ
MNNET%%%%4,**** "BBB@ HHHH **** "BBB@!"0!DTPOE6(!!P<;ACD+GKGI
MTYI7)"Y&/?)P,=3S_AS7DOQI^+/ASX'_  O\;_%/Q5*HT3P7H%WJ[V_F*D^J
MZ@L;+I>B6A(;-[K&HFVTJS4J1]INE+[(U=ACB,11PF'Q&*Q-2-'#X:A5Q->M
M.RA2HT(NI5E*[2MR1D]6K)>:,<1B:&$H5\5B:M*AAL+0J8G$5JLU&-*C0BZE
M6<[M+E45NY+\5?\ G._X+"?%>#QK^T=H7PYL9(I;+X.^$4L+TQ%&QXE\;_8?
M$&JQLP4;6ATJU\.6\L>YPL\$JG;)%(H_)Q>GT_\ UCZ\$5U'CSQGKGQ'\;^+
M?'_B>?[1X@\9^(]7\2ZM/EB!>ZQ?2WLD$>\LR00><EK:Q!BL4,")&$B,4*5M
M)\(^+=>L+W5=!\+>)-;TS3(VEU'4M)T35-1T^PB3=N>\O+.TFMK1$1&E9IY5
MPB,S':&(_@;B3-:_$W$.<9O"E6F\?C:U>G2A3J5JE/"4H4J>%I2C1IU9*.&P
MM.CS3<5%_6%)RBE<_P Z.)LWK\4\2YSG-.C7F\RQE?$T:5.E4K5*>"HSEA\+
M3<*-.M)1P^#H85SGRJ#^L^T<E%IF 3CL2?3_ #_GIZU]"_LF>!A\2?VFO@9X
M,DA6>VU3XD>'IM1@>,RH^EZ+=C7=5$BC&8SIVEW1<]D#$XP<?.P(8$XW9Z#.
M>!P>G&,]QD$\CIFOU<_X(]_#_P#X2C]J.^\:3Q.UK\,? .NZI'* S*FM>)@O
MA2QBD(!4M-IFI:Y-&N1(K6^Z/"JXHX1RUYQQ1P_EZ2G3Q6:81U(VYXO"X3$4
M\5C)2LVI0E0PU2DX?RSE)W2E;3@O+/[:XLX;RY0YX8G.,$ZT=)1>&PF*HXK%
M3;U3@Z6&<7'LYMZ*5OF?_@Y0^( U7]I3X"?#.*X<Q^"_@M?>-;BVP3%'>?$#
MQQK&DQ,>0!,UIX"B+@$G9-%P003_ #@5^J?_  6G^)0^)/\ P4=^/KP2RS6'
M@"7PG\,K M(9$B'A/PGI,6JQ0-T2*+Q1?:^9(EVHEV]P642.Q/Y6>_;UK_IF
M\'LJ>2>%_!&7S5JBR# XVKM%JOFT*V;5*;C97E!8^CKJVFE=N+:_&/&C-EG?
MBGQUF$)^TI/B+&X.E-)J/LLK5#*H15[KE7]G591U6DGHM4%+G("G[NX,V,9.
M.@YZCVR*3MGMZ]J,' ;'!) /8D=0#TR.X[5^D^2;3\K<VMMM&U=:;:J32^+7
M\P5TT[.]]'9[I[IZ>]%^MGNKK3TGX2_&/XH_ ?QQI?Q*^#_CCQ)\/?'&AG_B
M7>(_#&IS:;>BT9D-QI=_$GF6>K:+?[(XM2T35K:^TB_B"I>6=PBA!_0!\"O^
M#D#XY^$[:QTG]H/X+>#/B_;Q1Q1W7BOP-J]Q\-/%<ZJDA-W>:/-8^)?"6HW\
MI,"R6UA%X4L\B=A+$DD<</\ -NIRW'(&2X!R=J\L"._3!'\L9K]??^"/G_!/
M_P"&/[=OQ7^(EO\ %WQ;J6E^!_A%H?ACQ+?^!?#-U%IWBCXA-XBU/5K""W77
M)(IY-&\+:+)I*_\ "27&FPG6+E]6TBRLKO2C<M?-^4>*W#_AE6X=S/B/Q#R'
M#8[!9'@XSGCL+@V\\PE*M7AAJ%+#8K+ZN"S11=?$1C16,Q.*P<744)>QH>TB
M?L'A+Q'XFX?B'+>&_#W/L5@,9F^,Y(9?B,92_L*M.%*>)KU,9@LQIXO!0Y<+
MA,3B)SPF&HXJORV@YU_9R/[#?V&OV]?@Q^WMX"\2>-OA)8>-=$F\&:OI^@>,
M/#WC703IEWI&JZG8-J-FMCJMC<ZCX=URWN+>.:0OI>JS7MJJQ'5+#3EO;#[5
M]R+RJGV'7KTKRKX3?"+X9? SP1H_PV^#_@?PS\.O FA1A-+\->&--ATZR2:0
M#S[^[,0\_4]7U!@)-6UK5)[O6-4N]]YJ-[<7+O)7JB8"* <@* #U)P,9/OZY
MK_+G.ZV25\YS*KPW@L=EN0U,5.>58',\93S#'X?!^[&G#%8NE1P\)UGR2JRC
M"ERPC6IP52K[/VM3_57A^CGE#)\MH\28W!YEGM/"QAFF/R_"3P&!Q&+4KSGA
M<)4JUIPI*,XTN>4XN<Z%2?LJ/M/90I7MG]K62)B_E30O!($FD@<)(KJS12PL
MDL,F&^6:%TF0@&*6)@6/P)I/_!*W_@GYH>KZ5KNF?LI?"^+5-$U.RUK3+FZC
MUS4C#JNG7$=W97=Q%J6LWEO>O%<QK(5O(+F*4 I/'*CNI_0DLJ_>91TZD#KT
MZ^O:D+H 264 =26  ^O-/+L[SO*(XF&49SF^50QT%2QD,LS/'Y?'%TXPJ4U3
MQ"P6*PWMH*G5JP49\R4:M33FES*\RR#(\YGAYYOD^5YK/"2J2P<LRR[ YA+"
MSJ.$JTL-]<PN*=*52=.C*JZ?*Y2HT;VC3C!UUCD4CY$/*Y;=@[0R' 4( -HW
MC P#M4=\BU3=Z?WE[_Q#MU[]N_I2Y'J/S%>4DEIW[N[ETO=ZR:24;ZNT5=MW
M;]9)):;7;V22T5[6225XN5EHFY6LK1BM%(64 DLH ZDD8'U/:ER#T.:?EU[=
M?NW_  '_ ,/\GU"FN"58#J1QSCGZX./K@_0TZDR..1R0!R.2>@'N>U+39_-7
ML[?)IKU5GV:=A/9ZV\]-//5-75]+IJ]KI[/D_%O@SPYX^\*^(_!'C70M+\3>
M$O%VBZIX<\3^'=9MXK[2=<T+6+2:PU+2]1M)(_*N+2]L[B:&6-E'RL=I5\2#
MY#^'?_!-C]B+X1^-?#'Q(^&?[.7@?P;X]\':C'JWAOQ3HMYXFMM6TJ_2WEM'
MFAG;7)%F%Q:7%Q9W=O<Q2VU[9W%Q:W44D$\B'[II RG.&4XSG!'&.N?IW]*]
M3!9UG6687%X++LYS7+\%CX\N/PF"S#%X3"8V'L:F'<,9AL-7H8?$0=&K4IN-
M>E4C[.<Z=O9RE!^7C<AR3,L1A,9C\GRS&XS /FP.,Q>7X3%XK!2]M#$<V$Q.
M)P^(K8:7MZ4*W/2JTY>UBJG-[2*DL2_T:WU?2M1T;5K6&]TW5K*[TW4K*9BT
M-[I]_:R6E[:3X"LT4]O-) ^'WE&+>8')KY=^"7["'[)?[-_B^3Q]\"_@1X*^
M&GC*;0+_ ,+2>(?#YUC[>WA_5+O3;[4-+_T[5+R'[-=76CZ9-)B,2;K.+:Z8
M(/U[N7U'YBC(]1^8K'#9GF6$P>-P&%S/'X; YG"G#,L+A\;B:&%S&%-6IK'4
M*%>G0Q:CKRJO3JQCS-127*HWB<HRG&8K!8[%Y=@,5CLLG*IEN+Q.#PF(Q.7S
MG+GE+!5JV'J5<*Y2LVZ%2E)\L;N]W+XI^.?_  3O_8S_ &D=7G\1_&/]GGP!
MXE\579W7WB_38-1\'>+]2<,65M7\3^#+_P /ZUK14,V#J][>X))QS7RL_P#P
M0I_X)L/,TQ^"WB':Q)\C_A;/Q,,29).U5;Q,SE!P &F8XX)X)/Z_[E_O#\Q2
M!E/1E/.."#R.HX/6OH,OX_X[RC"T\'EO&G%6 P5&*A1PN'S_ #2GAJ,=$HT:
M$L95HT(I12C2HPITXI6A3BE9>!F'A[P'FV(JXS,N#>%\?BJTW4K8K$Y%E=2O
M5G)N3E5K+"4YU9RDY.52K.I5FVW.I-ZGY+V?_!#W_@FC:E&;]GNXN2I!*W/Q
M3^+#*Q!!!81>-(MPR!Z=^U>W_#G_ ()>_L"?"J\M=2\'_LJ?"EM2LI1/9W_B
M[3+OXA75I.%95N+:3Q]>^)?(F0,2DD*HZMAD*E5(^^LCU'YBDWH,Y=1C&?F'
M&>F>>_;U[4\7X@<>8ZG*AB^-N+:]&I%PJ49\19Q[.I&2:E&=.GCZ$:D6G).$
MHN+3=XO2RP7AWP!E]2%7 \%<)X:K":G3J4N'\H=2$UK&5.=3!8B<9Q:4HR@^
M:+BFFK,HV=E'9PPVL$$-O;6\,<%O%;HD4,$,0VQ00P1JD<,,2 )''$$C10%C
M15&#=V<J?[N>_7@X)Z?3'/'&<9IP(/0@_0YI:^0Y>]]6Y.]M6VW>3:<Y:MN\
MIRDY-RE*3;;^PC&,5'ET2BHIIJRC%)*R5H15DH^Y"$5%6BHI6163JFCV&M:=
M>:1J]AI^K:3J,$EIJ.EZI96^H:=J%G-&R36MY97B36US!*#B2*>&2.1"R.C
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M"-4_\.M\5?Z>+_Y\U;LO^"('_!-.R<N?V>I[TYR$OOBC\6)8UP>,+'XTAY(
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MX_-N*<RH>&7#+<<3C*5+&<4X^TOJ^5Y-.:=&GB*T5RP>)C_M,J#DZF(G2P>
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M1&V@EQYW_P -0_M,@?+^P-\5% R2H^)?PVQDG)QMO0 "22.AYSP" /5O@_\
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M-HMS_9ET)R96LYW>..&6UEN/F+XRB?\ ;&_:@T']FS36EN_@9^SOJ&C?$?\
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MNPZE[V+Q2>%CBJT*E/"->U5*I-J)Z\/VVO%JCS+C]BG]K>.WQDRQ>"=%GF"
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MU!SJ5UI\=I VHSO!8W\[Z;IZ6]Y]_);*B"/<2J@*JE8PJJ  %1$1$50
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MXK2[-I!<-<&VG$9BD\$\-_M1?M5>$]!T?0/'7["_Q/USQ)I&G66F:MK?P_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
:HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>abeo-20250320.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWayNybP9z5Z86ekhvWB4bdkKnyAgQhjhxymi/ek2waoG -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:ABEO="http://abeonatherapeutics.com/20250320" elementFormDefault="qualified" targetNamespace="http://abeonatherapeutics.com/20250320">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://abeonatherapeutics.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="abeo-20250320_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="abeo-20250320_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>abeo-20250320_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>abeo-20250320_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://abeonatherapeutics.com/role/Cover" xlink:href="abeo-20250320.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://abeonatherapeutics.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Mar. 20, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 20,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-15771<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ABEONA
THERAPEUTICS INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000318306<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">83-0221517<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6555
Carnegie Ave<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">4th Floor<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Cleveland<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">OH<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">44103<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(646)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">813-4701<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ABEO<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( +$]=%I&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( +$]=%K TE(M[P   "L"   1
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M@2";_-;;I/;=X Q\U*M:I60K$3]+!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F
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MS-?"5C;D[)$EM8G"=8+;R=-C<+%XF#P'L\FWQ70\)]/'\36"V"\1^^<@CF%
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M%@_&%Q 9Y=VI\0QKRTZ+Y2T].PP_/LG>V)+;.<V"3J9B+7D%=*RHC_#K3),
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MHAVE?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%
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M/UY_ 5!+ 0(4 Q0    ( +$]=%I&QTU(E0   ,T    0              "
M 0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ L3UT6L#24BWO
M*P(  !$              ( !PP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#
M%     @ L3UT6IE<G",0!@  G"<  !,              ( !X0$  'AL+W1H
M96UE+W1H96UE,2YX;6Q02P$"% ,4    " "Q/71:6\LJ'F($   ;$0  &
M            @($B"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#
M%     @ L3UT6I^@&_"Q @  X@P   T              ( !N@P  'AL+W-T
M>6QE<RYX;6Q02P$"% ,4    " "Q/71:EXJ[',     3 @  "P
M    @ &6#P  7W)E;',O+G)E;'-02P$"% ,4    " "Q/71:JL0B%C,!   B
M @  #P              @ %_$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%
M  @ L3UT6B0>FZ*M    ^ $  !H              ( !WQ$  'AL+U]R96QS
M+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ L3UT6F60>9(9 0  SP,
M !,              ( !Q!(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
/  D "0 ^ @  #A0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://abeonatherapeutics.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>abeo-20250320.xsd</File>
    <File>abeo-20250320_lab.xml</File>
    <File>abeo-20250320_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "ABEO",
   "nsuri": "http://abeonatherapeutics.com/20250320",
   "dts": {
    "schema": {
     "local": [
      "abeo-20250320.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "abeo-20250320_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "abeo-20250320_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 23
   },
   "report": {
    "R1": {
     "role": "http://abeonatherapeutics.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-03-20",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-03-20",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001493152-25-010981-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-25-010981-xbrl.zip
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M072RS9'9RY4&*9&O;OY"TD@DSVHYW]6.ALQYIUM,MOJ^I@D+@;8QF(2:UM/
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M-#4!D6 U!M!PT.;/E'HA8B9')H'IG,5D]S/9@^UJZ=PR =AL0F&( J+"[@S
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M@YJ&MB((%$!;)@<'(=)*QQ#<":(@)+(C\I< 56(A<?OP8)WMN\2NH.@WK.&
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MO135*T K]8Q8607Z356"\EILOU]>WW0M/\G->I/\:X53(K?\%U!+ P04
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MYMHV]!2^*0(4A\8']8U"8 P58;KH'.BZM0?<.VN+;]PO]UY6>^1_4$L#!!0
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M83B W1XX BXZ XH)0Z\/^KG/'-#W+O$82ABPG0>/#91D<KRK![Q@B]!UT!!
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MDS_-<7X;HIG+):M0_'6U<[EHE9.9P357T>\(]K6*54^^$VEE:%^WBLGC3%*
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M.)6]9=3>AE-YZU'Y>H#IVG30.T9G\K<$] ?(@+^E =%D^&?55'QWV\,J)6^
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MZ&E-40E(M$O,<*6TV]JC>G]^4W[\#>>56E2ZV;QL&T"("9G=76&C8M]#Q<2
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M.QQ)='5YPG[VK8%:_!]02P$"% ,4    " "Q/71:X@2# "\#   !#   $0
M            @ $     86)E;RTR,#(U,#,R,"YX<V102P$"% ,4    " "Q
M/71:(<O)9OX*  " A@  %0              @ %> P  86)E;RTR,#(U,#,R
M,%]L86(N>&UL4$L! A0#%     @ L3UT6H1&P8Y>!P  Z5<  !4
M     ( !CPX  &%B96\M,C R-3 S,C!?<')E+GAM;%!+ 0(4 Q0    ( +$]
M=%I 0_#X=QP  -/Q   *              "  2 6  !E>#DY+3$N:'1M4$L!
M A0#%     @ L3UT6KP$L\Z5$@  4XX   L              ( !OS(  &9O
?<FTX+6LN:'1M4$L%!@     %  4 -@$  'U%      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="abeo-20250320.xsd" xlink:type="simple"/>
    <context id="AsOf2025-03-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000318306</identifier>
        </entity>
        <period>
            <startDate>2025-03-20</startDate>
            <endDate>2025-03-20</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-03-20" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-03-20" id="Fact000004">0000318306</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-03-20" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-03-20" id="Fact000010">2025-03-20</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-03-20" id="Fact000011">ABEONA THERAPEUTICS INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-03-20" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-03-20" id="Fact000013">001-15771</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-03-20" id="Fact000014">83-0221517</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-03-20" id="Fact000015">6555 Carnegie Ave</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-03-20" id="Fact000016">4th Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-03-20" id="Fact000017">Cleveland</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-03-20" id="Fact000018">OH</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-03-20" id="Fact000019">44103</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-03-20" id="Fact000020">(646)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-03-20" id="Fact000021">813-4701</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-03-20" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-03-20" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-03-20" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-03-20" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-03-20" id="Fact000026">Common     Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-03-20" id="Fact000027">ABEO</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-03-20" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-03-20" id="Fact000029">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
